Skip to content
PubMed This is a summary of 45 peer-reviewed journal articles Updated
Neurology

Understanding Your Diagnosis: An Overview of Neuralgic Amyotrophy

At a Glance

Neuralgic Amyotrophy, or Parsonage-Turner Syndrome, is an immune-mediated disorder attacking the brachial plexus nerves. It causes sudden, severe shoulder and arm pain followed by progressive muscle weakness. An accurate diagnosis by a specialized neuromuscular care team is critical.

If you are reading this, you have likely experienced a sudden, terrifying onset of pain in your shoulder or arm that felt unlike anything you’ve ever felt before. You may have spent weeks or even months visiting different doctors, only to be told it was a “pulled muscle,” “rotator cuff tear,” or simply “stress.”

Neuralgic Amyotrophy (NA), also known as Parsonage-Turner Syndrome (PTS), is an immune-mediated inflammatory disorder where your body’s immune system mistakenly attacks the brachial plexus [1][2]. You can think of the brachial plexus as a complex electrical junction box in your neck and upper chest that wires your spinal cord to your shoulder, arm, and hand. While it was once considered a “rare” condition, we now know it is far more common than previously thought.

You Are Not Alone (and You’re Not Imagining It)

For decades, medical textbooks estimated that NA affected about 1 to 3 people out of every 100,000 [3]. However, modern research suggests the real number is 30 to 50 times higher [3]. Because many doctors are still taught the “rare” statistics, the condition is frequently under-recognized or misdiagnosed [4][5].

This “diagnostic odyssey”—the long, frustrating journey to find an answer—is often as exhausting as the physical pain itself [5][6]. Validation is the first step toward recovery: your pain is real, your weakness is documented, and there is a biological reason for what is happening to your body [1][7].

The Two Phases of the Condition

Neuralgic Amyotrophy typically follows a distinct, two-stage pattern:

  1. The Acute Pain Phase: This begins with a sudden, “out of the blue” explosion of pain, usually in the shoulder or upper arm [7][8]. Patients often describe this pain as the most severe they have ever experienced [8]. It is often constant, worse at night, and frequently resistant to standard over-the-counter painkillers [7][1].
  2. The Weakness and Atrophy Phase: As the initial pain begins to subside (often after a few days or weeks), it is replaced by progressive muscle weakness [1][7]. You may notice atrophy (visible thinning or wasting away of the muscle) and difficulty lifting your arm or performing fine motor tasks [1][8].

What Triggers the Attack?

While the exact cause is still being studied, NA is believed to be triggered by an “immune event” that sensitizes the nerves to inflammation [1][2]. Common triggers include:

  • Viral Infections: Such as Hepatitis E, COVID-19, or Parvovirus B19 [9][10][11].
  • Vaccinations: In some cases, a vaccine can stimulate the immune system in a way that triggers an episode [9][12].
  • Physical Stress: This includes surgeries, childbirth, or heavy physical exertion [13][14].
  • Idiopathic/Unknown: It is very important to note that in many cases, no specific trigger is ever identified. If you cannot point to a prior illness or event, it is still completely normal.

Finding the Right Care Team

Because NA is frequently misunderstood, finding a care team that understands the modern reality of this condition is the most important step forward [15][3]. You should actively seek out specialists such as:

  • Neuromuscular Neurologists: Neurologists who specialize specifically in peripheral nerve diseases.
  • Physiatrists (Physical Medicine & Rehabilitation): Doctors who specialize in nerve and muscle rehabilitation.
  • Peripheral Nerve Surgeons: If you have persistent symptoms after several months, to evaluate for structural nerve blockages.

Is It Hereditary?

Most cases are “idiopathic,” meaning they happen once without a clear genetic link [16]. However, there is a version called Hereditary Neuralgic Amyotrophy (HNA) [16].

  • HNA is often caused by a mutation in the SEPT9 gene [10][16].
  • Unlike the idiopathic version, HNA is characterized by recurrent episodes (attacks that happen multiple times throughout life) [16][17].

Understanding whether your condition is hereditary is important because it can help predict the risk of future episodes and inform other family members [10][16]. No matter which form you have, getting to the right specialist is your next best step. For more details on what to expect, explore the pages in this guide.

Common questions in this guide

What are the first signs of Neuralgic Amyotrophy?
The condition typically begins with a sudden, severe explosion of pain in the shoulder or upper arm. This acute pain phase is often constant, worse at night, and rarely responds well to standard over-the-counter pain medications.
Is Neuralgic Amyotrophy the same as Parsonage-Turner Syndrome?
Yes, Neuralgic Amyotrophy is frequently referred to as Parsonage-Turner Syndrome. Both names describe the exact same immune-mediated inflammatory disorder that attacks the brachial plexus nerves in the neck and chest.
What causes a Neuralgic Amyotrophy attack?
Attacks are believed to be triggered by an immune event that causes nerve inflammation. Common triggers include viral infections, recent vaccinations, or significant physical stress like surgery or childbirth, though many cases happen without any clear cause.
Is Neuralgic Amyotrophy a hereditary condition?
Most cases happen once without a clear genetic link. However, there is a hereditary form called Hereditary Neuralgic Amyotrophy (HNA), often caused by a mutation in the SEPT9 gene, which can lead to multiple recurring nerve attacks throughout life.
What kind of doctor should I see for Parsonage-Turner Syndrome?
Because the condition is frequently misdiagnosed, it is important to see specialists who understand peripheral nerve diseases. This typically includes neuromuscular neurologists, physiatrists who specialize in nerve rehabilitation, and sometimes peripheral nerve surgeons.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given that neuralgic amyotrophy is more common than previously thought, how often do you see and treat this condition in your practice?
  2. 2.What was my likely trigger (such as a recent infection, surgery, or vaccination), and how does that influence my management plan?
  3. 3.Could my symptoms be the hereditary form of this condition, and should I consider genetic testing?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (17)
  1. 1

    Parsonage-Turner syndrome after COVID-19 infection.

    Voss TG, Stewart CM

    JSES reviews, reports, and techniques 2022; (2(2)):182-185 doi:10.1016/j.xrrt.2021.12.004.

    PMID: 35039808
  2. 2

    Clinico-diagnostic features of neuralgic amyotrophy in childhood.

    Rotondo E, Pellegrino N, Di Battista C, et al.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2020; (41(7)):1735-1740 doi:10.1007/s10072-020-04314-8.

    PMID: 32140911
  3. 3

    Incidence of neuralgic amyotrophy (Parsonage Turner syndrome) in a primary care setting--a prospective cohort study.

    van Alfen N, van Eijk JJ, Ennik T, et al.

    PloS one 2015; (10(5)):e0128361 doi:10.1371/journal.pone.0128361.

    PMID: 26016482
  4. 4

    Neuralgic amyotrophy triggered by cytomegalovirus: to be aware of this clinical diagnosis.

    Scanvion Q, Morell-Dubois S

    Neurocase 2022; (28(3)):320-322 doi:10.1080/13554794.2022.2085118.

    PMID: 35654085
  5. 5

    Neuralgic Amyotrophy Attributed Incorrectly to Block-Related Injury: Understanding Errors in Clinical Reasoning.

    Neal JM, Porter SS, Wilson BP

    Regional anesthesia and pain medicine 2017; (42(5)):645-648 doi:10.1097/AAP.0000000000000632.

    PMID: 28665875
  6. 6

    Extremely Painful Multifocal Acquired Predominant Axonal Sensorimotor Neuropathy of the Upper Limb.

    Lieba-Samal D, van Eijk JJJ, van Rosmalen MHJ, et al.

    Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine 2018; (37(6)):1565-1574 doi:10.1002/jum.14492.

    PMID: 29159899
  7. 7

    [Parsonage-Turner syndrome: Unknown but not infrequent. Apropos of 6 cases].

    Martínez Bermúdez CM, Fernández de Gea I, Yusá Cubes B, Valera Martínez H

    Rehabilitacion 2019; (53(1)):56-59 doi:10.1016/j.rh.2018.05.001.

    PMID: 30929832
  8. 8

    Bilateral Brachial Neuritis after COVID-19: Case Report.

    Abdouni YA, Viamont-Guerra MR

    Revista brasileira de ortopedia 2024; (59(Suppl 2)):e173-e175 doi:10.1055/s-0042-1750756.

    PMID: 39735454
  9. 9

    Parsonage Turner syndrome after cervical trauma and COVID-19 infection: a case report and review of the literature.

    Ahorukomeye P, Pennacchio CA, Preston DC, Cheng CW

    AME case reports 2022; (6()):37 doi:10.21037/acr-22-33.

    PMID: 36339906
  10. 10

    Parsonage-Turner Syndrome and Hereditary Brachial Plexus Neuropathy.

    Meiling JB, Boon AJ, Niu Z, et al.

    Mayo Clinic proceedings 2024; (99(1)):124-140 doi:10.1016/j.mayocp.2023.06.011.

    PMID: 38176820
  11. 11

    COVID-19 atypical Parsonage-Turner syndrome: a case report.

    Zazzara MB, Modoni A, Bizzarro A, et al.

    BMC neurology 2022; (22(1)):96 doi:10.1186/s12883-022-02622-4.

    PMID: 35296278
  12. 12

    Parsonage-Turner Syndrome as a Rare Extrahepatic Complication of Hepatitis E Infection.

    Njabom CN, Gilbert A, Brasseur E, et al.

    European journal of case reports in internal medicine 2019; (6(8)):001208 doi:10.12890/2019_001208.

    PMID: 31508389
  13. 13

    Development of Parsonage-Turner Syndrome After Heat Stroke in Firefighters: A Report of 2 Cases.

    Eliasberg CD, Sneag DB, Kelly AM

    JBJS case connector 2020; (10(2)):e19.00462 doi:10.2106/JBJS.CC.19.00462.

    PMID: 32649151
  14. 14

    Parsonage-Turner Syndrome After COVID-19 Vaccination: A Case Report.

    Ghanta RB, Karistinos A, Atassi OH

    JBJS case connector 2022; (12(2)) doi:10.2106/JBJS.CC.21.00550.

    PMID: 37440679
  15. 15

    The Utility of an Epidural Steroid Injection for the Treatment of Idiopathic Brachial Neuritis.

    Dickey Z, Sharma N

    Cureus 2024; (16(3)):e57211 doi:10.7759/cureus.57211.

    PMID: 38681293
  16. 16

    A rare cause of brachial plexopathy: hereditary neuralgic amyotrophy.

    Serin HM, Yılmaz S, Kanmaz S, et al.

    Turk pediatri arsivi 2019; (54(3)):189-191 doi:10.5152/TurkPediatriArs.2018.5837.

    PMID: 31619932
  17. 17

    Teaching NeuroImages: Slowly progressive hypertrophic brachial plexopathy due to SEPT9 mutation.

    Souza PVS, Gonçalves EA, Badia BML, et al.

    Neurology 2020; (95(1)):e109-e110 doi:10.1212/WNL.0000000000009739.

    PMID: 32522797

This page provides an educational overview of Neuralgic Amyotrophy and Parsonage-Turner Syndrome. It is for informational purposes only and does not replace professional medical advice, diagnosis, or evaluation by a qualified specialist.

Get notified when new evidence is published on Neuralgic amyotrophy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.